Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
Microbix Reports Continued Strong Results for Q3 Fiscal 2024
-
Alliance Trust PLC - Net Asset Value
-
Base Carbon Reports Second-Quarter 2024 Operating and Financial Results
-
Trinity Biotech Announces Q2 2024 Financial Results
-
Prime Drink Group Corp. Enters Into a Final Share Purchase Agreement to Acquire Triani Canada Inc.
-
Dundee Corporation Announces the Redemption of its Series 2 and Series 3 Preference Shares
-
CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update
-
Veralox Therapeutics Announces EMA Orphan Drug Designation for VLX-1005
-
Titan Further Amends Amalgamation Agreement with Conavi Medical Inc. and Announces Further Extension of 2024 Annual General and Special Meeting
-
Verrica Pharmaceuticals Announces Positive Preliminary Topline Results from Part 2 of Phase 2 Clinical Study of VP-315, an Investigational Oncolytic Peptide-Based Immunotherapy for the Treatment of Pa
-
Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call
-
WinVest Acquisition Corp. Announces Extension of Termination Date and Additional Contribution to Trust Account to Extend Termination Date
-
FitLife Brands Announces Second Quarter 2024 Results
-
Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors
-
Atsena Therapeutics Receives Rare Pediatric Disease Designation from the U.S. FDA for ATSN-201 Gene Therapy to Treat X-linked Retinoschisis
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 12 08 2024] - (CGWL)
-
ROCKWOOL A/S – transactions in connection with share buy-back programme
-
Dada to Announce Unaudited Second Quarter 2024 Financial Results on August 20, 2024
-
Girls Club Token $GIRLS Is Here to Break up Crypto’s Old Boy Network
-
Unicycive Announces Second Quarter 2024 Financial Results and Provides Business Update
-
Hofseth Biocare ASA: GROUNDBREAKING STUDY REVEALS HOFSETH BIOCARE’S FULL SPECTRUM OMEGAS OMEGO SUPPORTS COVID-19 RECOVERY
-
Panavance Therapeutics Announces Foundational Publication of Misetionamide (GP-2250) in Ovarian Cancer in the Journal, Cancer Medicine
-
Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
-
Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corporate Update
-
Forsys Reports Additional Interim Drilling Results from Norasa
-
Marex Group plc announces 2024 Interim Results
-
Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research
-
Boralex announces net earnings of $17M for the second quarter of 2024, an increase in its financial flexibility and on-track progress of projects in growth path totaling 851 MW
-
Victoria’s Secret & Co. Appoints Hillary Super Chief Executive Officer
-
Formation Minerals, Inc. Provides Fiscal Year End Corporate Update
-
CCC, Spain sign contract for DHC-515 FIREFIGHTER™ aircraft
-
Kamada Reports Strong Second Quarter and First Half 2024 Financial Results with Year-Over-Year 6-Month Top-Line Growth of 18% and a 68% Increase in Profitability
-
Aya Gold & Silver: Strong Q2-2024 Results
-
Viracta Therapeutics Announces Positive Data from the Phase 2 NAVAL-1 Trial, Regulatory Progress, and Updated Nana-val Clinical Development Plan
-
Sachem Capital Reports Second Quarter 2024 Results – Reports Quarterly Revenues of $15.1 Million
-
Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates
-
Edible Garden Reports 157% Increase in Gross Profit Fueled by Year-over-Year Growth of 61% in Cut Herbs and 30% in Vitamins & Supplements for the Second Quarter of 2024
-
Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders
-
Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
-
Mondee Reports Second Quarter 2024 Results and Announces Comprehensive Long-Term Refinancing of its Capital Structure
-
PolyPid Provides Corporate Update and Reports Second Quarter 2024 Financial Results
-
JOYY to Announce Second Quarter 2024 Financial Results on August 27, 2024
-
Data Storage Corporation Reports 2024 Second Quarter Financial Results and Provides Business Update
-
Zapata AI Announces Second Quarter 2024 Financial Results and Provides Business Update
-
C4 Therapeutics Announces European Society for Medical Oncology (ESMO) Changed the Previously Accepted CFT1946 Preliminary Phase 1 Abstract to a Proffered Paper Presentation
-
Telesat Reports Results for the Quarter and Six Months Ended June 30, 2024
-
Singing Machine to Announce its Financial Results for the Second Quarter of 2024
-
Fiverr and Martha Stewart Team Up in Witty Ad Campaign Encouraging Businesses to Rethink What’s Possible with Freelancers
-
MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update
